Canada Generic Drug Market Share, Size Trends and Forecast 2017-2022

1

Canada Generic Drug Market Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2017-2022
Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Canada Generic Drug Market Driven by Changing
Demographics and Government Initiatives The
Canada generic drug market has witnessed a
significant growth over the past several years,
reaching a volume of around 0.46 Billion Units in
2016. This can be attributed to public and
private sector drugs programs and healthcare
initiatives promoting the use of generic
drugs. Canada currently represents the
ninth-largest generic drug market worldwide,
accounting for nearly 3 of the total global
share. The share of generic drugs in the
pharmaceuticals market has increased
significantly over the past several years. At
present, generic drugs account for around 70 of
the total retail prescriptions, and 22 of the
total pharmaceutical sales value in the region.
This can be attributed to the various public and
private sector drug programs aimed at
cost-containment and increasing awareness about
generic drugs. The latest report by IMARC Group
titled, Canada Generic Drug Market Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2017-2022, finds that the Canada
generic drug market reached a volume of around
0.46 Billion Units in 2016, growing at a CAGR of
around 8 during 2010-2016. Get Sample of
Report http//www.imarcgroup.com/request?typerep
ortid721flagB
4
Report Description and Highlights
Report Description
5
Report Description and Highlights
Report Description

• Highlights of the Canada Generic Drug Market
• Generic drugs account for nearly 70 of the total
  retail prescriptions in Canada.
• Changing demographics and government initiatives
  are the major growth driver
• Patent expiry of a number of blockbuster drugs is
  expected to provide growth opportunities.
• Population growth, changing demographics,
  increasing prevalence of chronic diseases and a
  rise in the use of drug therapy are projected to
  put more pressure on Government healthcare
  initiatives such as the drug benefit plans
  operative in the Canadian territories and
  provinces. As the sustainability of these
  programmes is largely dependent on the use of
  generic drugs, the demand for these drugs is
  expected to increase over the next several years.
  Moreover, the patent expiry of a number of
  blockbuster drugs is also anticipated to expand
  the generic drug market in Canada. According to
  the report, the market is further expected to
  reach a volume of nearly 0.7 Billion Units by
  2022.
• The report analyses the competitive landscape of
  the market and provides details of the major
  players in the market. Some of these include Teva
  Pharmaceutical Ltd., Apotex Inc., Snadoz Canada,
  Actavis, Mylan, Pharmascience Inc., Taro
  Pharmaceuticals, Novartis, Ranbaxy
  Pharmaceuticals Canada and Hospira. The report
  provides a comprehensive insight into the
  historical and current trends as well as the
  future prospects of the generic drug market in
  Canada.

6
Report Description and Highlights
Report Description
This study serves as an exceptional tool to
understand the sales trends, volume trends,
growth, key segments, competitive structure,
regulations, major manufacturer, major
distributors, top drugs, manufacturing
requirements, opportunities and future prospects
of the Canada generic drug market. This report
can serve as an excellent guide for
manufacturers, consultants, researchers,
marketing strategists and all those who plan to
foray into the Canada generic drug market in any
form. Browse full report with TOC _at_
http//www.imarcgroup.com/canada-generic-drug-mark
et Find more research reports related to
Healthcare Industry _at_ http//www.imarcgroup.com/ca
tegories/healthcare-market-research-reports

7
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
8

Contact Us